Medicamen Biotech Limited reported earnings results for the first quarter ended June 30, 2023. For the first quarter, the company reported sales was INR 419.43 million compared to INR 330.88 million a year ago. Revenue was INR 423.22 million compared to INR 340.5 million a year ago.

Net income was INR 41.77 million compared to INR 35.86 million a year ago. Basic earnings per share from continuing operations was INR 3.12 compared to INR 2.94 a year ago. Diluted earnings per share from continuing operations was INR 3.12 compared to INR 2.94 a year ago.